8-KLeadership Changes

CSX CORP 8-K Report, Executive Changes (Jul 12, 2023)

Filed July 12, 2023For Securities:CSX

Summary

CSX Corporation (CSX) filed an 8-K on July 12, 2023, detailing amendments to its Executive Severance Plan and the approval of renewed Change of Control Agreements for its executive officers. The primary focus of the amendment to the Executive Severance Plan is to clarify the treatment of outstanding equity awards upon a qualifying termination of employment. Specifically, in the event of a termination without cause, outstanding equity awards will vest on a pro-rata basis and remain exercisable according to their original terms, with performance-based awards still subject to satisfaction of performance conditions. Furthermore, CSX has renewed its Change of Control Agreements for executive officers, which largely retain the same compensation and benefit terms as the prior agreements. Key updates include a rolling three-year term with automatic extensions and specific termination protection provisions for executives terminated without cause or for good reason shortly before a change of control. These changes are designed to provide clarity and continued executive retention incentives.

Key Highlights

  • 1CSX amended its Executive Severance Plan to clarify equity award treatment upon termination without cause.
  • 2Under the amended plan, outstanding equity awards will vest on a pro-rata basis and retain original exercise terms upon termination without cause.
  • 3Performance-based equity awards will still require satisfaction of performance conditions under the amended severance plan.
  • 4CSX renewed Change of Control Agreements for its executive officers, maintaining similar compensation and benefit terms.
  • 5Renewed Change of Control Agreements feature a three-year rolling term with automatic extensions.
  • 6New termination protection provisions are included for executives terminated without cause or for good reason within three months prior to a change of control.

Frequently Asked Questions

The main change clarifies how outstanding equity awards are treated if an executive is terminated without 'cause.' These awards will now vest on a pro-rata basis and remain exercisable according to their original terms, with performance-based awards still contingent on meeting performance conditions.

The renewed Change of Control Agreements largely maintain the same compensation and benefit terms as the previous agreements. The key updates involve a renewable three-year term and enhanced termination protection for executives terminated without cause or for good reason in close proximity to a change of control.

If an executive is terminated without cause, their vested stock options (including those that vest on a pro-rata basis) will remain exercisable until the original expiration date specified in their award agreement, which is typically not later than 10 years from the grant date.

The full text of the amended Executive Severance Plan and a form of the renewed Change of Control Agreements are expected to be attached as exhibits to CSX's Quarterly Report on Form 10-Q for the quarter ending September 30, 2023.